Intraocular implants for extended drug delivery: Therapeutic applications
- 15 November 2006
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 58 (11), 1182-1202
- https://doi.org/10.1016/j.addr.2006.07.026
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Ocular delivery using poly(ortho esters)Advanced Drug Delivery Reviews, 2005
- Development, implantation, in vivo elution, and retrieval of a biocompatible, sustained release subretinal drug delivery systemJournal of Biomedical Materials Research Part A, 2005
- Ocular Pharmacokinetics of Fluocinolone Acetonide After Retisert™ Intravitreal Implantation in Rabbits Over a 1-Year PeriodJournal of Ocular Pharmacology and Therapeutics, 2004
- Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradationJournal of Biomedical Materials Research Part A, 2003
- Intraocular Tissue Distribution of Betamethasone after Intrascleral Administration Using a Non-biodegradable Sustained Drug Delivery DeviceInvestigative Ophthalmology & Visual Science, 2003
- Particle Formation by a Conserved Domain of the Herpes Simplex Virus Protein VP22 Facilitating Protein and Nucleic Acid DeliveryPublished by Elsevier BV ,2001
- Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradationBiomaterials, 2000
- Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir ImplantThe New England Journal of Medicine, 1997
- Pharmacokinetics of Etoposide Delivery by a Bioerodible Drug Carrier Implanted at Glaucoma SurgeryJournal of Ocular Pharmacology and Therapeutics, 1994
- Macrophage phagocytosis of biodegradable microspheres composed of L‐lactic acid/glycolic acid homo‐ and copolymersJournal of Biomedical Materials Research, 1988